{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:56:05Z","timestamp":1791608165116,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Grants-in-Aid from the Ministry of Education, Culture, Sport, Science and Technology of Japan"},{"name":"Grants-in Aid from the Ministry of Health, Labour and Welfare of Japan"},{"name":"a grant for Research and Development Project III of Yokohama City University"},{"name":"grants for medical research from Takeda Science Foundation for Visionary Research"},{"DOI":"10.13039\/501100007263","name":"Astellas Foundation for Research on Metabolic Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1084-x","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T23:18:38Z","timestamp":1518823118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation"],"prefix":"10.1186","volume":"15","author":[{"given":"Keita","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Kunii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Fukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Tomita-Katsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Higashiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Joki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Koyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"1084_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fnins.2014.00315","volume":"8","author":"G Singhal","year":"2014","unstructured":"Singhal G, Jaehne EJ, Corrigan F, Toben C, Baune BT. Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci. 2014;8:315.","journal-title":"Front Neurosci"},{"key":"1084_CR2","doi-asserted-by":"publisher","first-page":"e48370","DOI":"10.1371\/journal.pone.0048370","volume":"7","author":"B Bielekova","year":"2012","unstructured":"Bielekova B, Komori M, Xu Q, Reich DS, Wu T. Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation. PLoS One. 2012;7:e48370.","journal-title":"PLoS One"},{"key":"1084_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302.","journal-title":"Ann Neurol"},{"key":"1084_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/jamaneurol.2014.3537","volume":"72","author":"DL Rotstein","year":"2015","unstructured":"Rotstein DL, Healy BC, Malik MT, Chitnis T, Weiner HL. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort. Jama Neurology. 2015;72:152\u20138.","journal-title":"Jama Neurology"},{"key":"1084_CR5","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/jcbfm.2012.53","volume":"32","author":"AH Jacobs","year":"2012","unstructured":"Jacobs AH, Tavitian B, Consortium IN. Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab. 2012;32:1393\u2013415.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1084_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1126\/science.1204144","volume":"333","author":"Y Sato","year":"2011","unstructured":"Sato Y, Iketani M, Kurihara Y, Yamaguchi M, Yamashita N, Nakamura F, Arie Y, Kawasaki T, Hirata T, Abe T, et al. Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Science. 2011;333:769\u201373.","journal-title":"Science"},{"key":"1084_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/1673-5374.150652","volume":"10","author":"Y Kurihara","year":"2015","unstructured":"Kurihara Y, Takei K. LOTUS, a potent blocker of Nogo receptor-1 causing inhibition of axonal growth. Neural Regen Res. 2015;10:46\u20138.","journal-title":"Neural Regen Res"},{"key":"1084_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.mcn.2014.07.001","volume":"61","author":"Y Kurihara","year":"2014","unstructured":"Kurihara Y, Iketani M, Ito H, Nishiyama K, Sakakibara Y, Goshima Y, Takei K. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand. Mol Cell Neurosci. 2014;61:211\u20138.","journal-title":"Mol Cell Neurosci"},{"key":"1084_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamaneurol.2014.3613","volume":"72","author":"K Takahashi","year":"2015","unstructured":"Takahashi K, Kurihara Y, Suzuki Y, Goshima Y, Tanaka F, Takei K. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis. JAMA Neurol. 2015;72:176\u20139.","journal-title":"JAMA Neurol"},{"key":"1084_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2217\/nmt.15.47","volume":"5","author":"K Takahashi","year":"2015","unstructured":"Takahashi K, Tanaka F, Takei K. LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis. Neurodegener Dis Manag. 2015;5:469\u201372.","journal-title":"Neurodegener Dis Manag"},{"key":"1084_CR11","first-page":"82","volume":"68","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Tanaka F, Takei K. Axonal regeneration-related molecules as biomarkers for multiple sclerosis. Brain Nerve. 2016;68:82\u20139.","journal-title":"Brain Nerve"},{"key":"1084_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132:1175\u201389.","journal-title":"Brain"},{"key":"1084_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.conb.2006.12.001","volume":"17","author":"T Yamashita","year":"2007","unstructured":"Yamashita T, Mueller BK, Hata K. Neogenin and repulsive guidance molecule signaling in the central nervous system. Curr Opin Neurobiol. 2007;17:29\u201334.","journal-title":"Curr Opin Neurobiol"},{"key":"1084_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.2321","volume":"17","author":"R Muramatsu","year":"2011","unstructured":"Muramatsu R, Kubo T, Mori M, Nakamura Y, Fujita Y, Akutsu T, Okuno T, Taniguchi J, Kumanogoh A, Yoshida M, et al. RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis. Nat Med. 2011;17:488\u201394.","journal-title":"Nat Med"},{"key":"1084_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0896-6273(00)80672-8","volume":"22","author":"HH Yu","year":"1999","unstructured":"Yu HH, Kolodkin AL. Semaphorin signaling: a little less per-plexin. Neuron. 1999;22:11\u20134.","journal-title":"Neuron"},{"key":"1084_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ni1553","volume":"9","author":"K Suzuki","year":"2008","unstructured":"Suzuki K, Kumanogoh A, Kikutani H. Semaphorins and their receptors in immune cell interactions. Nat Immunol. 2008;9:17\u201323.","journal-title":"Nat Immunol"},{"key":"1084_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.expneurol.2009.03.014","volume":"217","author":"M Pool","year":"2009","unstructured":"Pool M, Niino M, Rambaldi I, Robson K, Bar-Or A, Fournier AE. Myelin regulates immune cell adhesion and motility. Exp Neurol. 2009;217:371\u20137.","journal-title":"Exp Neurol"},{"key":"1084_CR18","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/brain\/aws100","volume":"135","author":"S Petratos","year":"2012","unstructured":"Petratos S, Ozturk E, Azari MF, Kenny R, Lee JY, Magee KA, Harvey AR, McDonald C, Taghian K, Moussa L, et al. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Brain. 2012;135:1794\u2013818.","journal-title":"Brain"},{"key":"1084_CR19","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1086\/425368","volume":"39","author":"AR Tunkel","year":"2004","unstructured":"Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267\u201384.","journal-title":"Clin Infect Dis"},{"key":"1084_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1474-4422(05)70019-3","volume":"4","author":"GE Thwaites","year":"2005","unstructured":"Thwaites GE, Hien TT. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005;4:160\u201370.","journal-title":"Lancet Neurol"},{"key":"1084_CR21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/35000219","volume":"403","author":"MS Chen","year":"2000","unstructured":"Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000;403:434\u20139.","journal-title":"Nature"},{"key":"1084_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/35053072","volume":"409","author":"AE Fournier","year":"2001","unstructured":"Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 2001;409:341\u20136.","journal-title":"Nature"},{"key":"1084_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1074\/jbc.M115.683615","volume":"291","author":"GF Grabner","year":"2016","unstructured":"Grabner GF, Eichmann TO, Wagner B, Gao Y, Farzi A, Taschler U, Radner FP, Schweiger M, Lass A, Holzer P, et al. Deletion of monoglyceride lipase in astrocytes attenuates lipopolysaccharide-induced neuroinflammation. J Biol Chem. 2016;291:913\u201323.","journal-title":"J Biol Chem"},{"key":"1084_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jneuroim.2016.10.004","volume":"300","author":"N Behairi","year":"2016","unstructured":"Behairi N, Belkhelfa M, Rafa H, Labsi M, Deghbar N, Bouzid N, Mesbah-Amroun H, Touil-Boukoffa C. All-trans retinoic acid (ATRA) prevents lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment in aged rats. J Neuroimmunol. 2016;300:21\u20139.","journal-title":"J Neuroimmunol"},{"key":"1084_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55:453\u201362.","journal-title":"Glia"},{"key":"1084_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neurobiolaging.2004.03.012","volume":"26","author":"J Zhang","year":"2005","unstructured":"Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, Wang Q, Pan C, Yi E, Eng J, Aebersold RH, Montine TJ. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol Aging. 2005;26:207\u201327.","journal-title":"Neurobiol Aging"},{"key":"1084_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1191\/1352458504ms1023oa","volume":"10","author":"BN Hammack","year":"2004","unstructured":"Hammack BN, Fung KY, Hunsucker SW, Duncan MW, Burgoon MP, Owens GP, Gilden DH. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler. 2004;10:245\u201360.","journal-title":"Mult Scler"},{"key":"1084_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","volume":"44","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir G, Tuzun E, Icoz S, Yesilot N, Yentur SP, Kurtuncu M, Mutlu M, Saruhan-Direskeneli G. Interleukin-6 in neuro-Behcet\u2019s disease: association with disease subsets and long-term outcome. Cytokine. 2008;44:373\u20136.","journal-title":"Cytokine"},{"key":"1084_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1006\/clin.1996.4268","volume":"82","author":"S Hirohata","year":"1997","unstructured":"Hirohata S, Isshi K, Oguchi H, Ohse T, Haraoka H, Takeuchi A, Hashimoto T. Cerebrospinal fluid interleukin-6 in progressive neuro-Behcet\u2019s syndrome. Clin Immunol Immunopathol. 1997;82:12\u20137.","journal-title":"Clin Immunol Immunopathol"},{"key":"1084_CR30","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1651-2227.1995.tb13784.x","volume":"84","author":"Y Matsuzono","year":"1995","unstructured":"Matsuzono Y, Narita M, Akutsu Y, Togashi T. Interleukin-6 in cerebrospinal fluid of patients with central nervous system infections. Acta Paediatr. 1995;84:879\u201383.","journal-title":"Acta Paediatr"},{"key":"1084_CR31","first-page":"320","volume":"71","author":"FA Houssiau","year":"1988","unstructured":"Houssiau FA, Bukasa K, Sindic CJ, Van Damme J, Van Snick J. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol. 1988;71:320\u20133.","journal-title":"Clin Exp Immunol"},{"key":"1084_CR32","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","volume":"256","author":"A Uzawa","year":"2009","unstructured":"Uzawa A, Mori M, Ito M, Uchida T, Hayakawa S, Masuda S, Kuwabara S. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis. J Neurol. 2009;256:2082\u20134.","journal-title":"J Neurol"},{"key":"1084_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1468-1331.2002.00437.x","volume":"9","author":"D Miljkovic","year":"2002","unstructured":"Miljkovic D, Drulovic J, Trajkovic V, Mesaros S, Dujmovic I, Maksimovic D, Samardzic T, Stojsavljevic N, Levic Z, Mostarica SM. Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients. Eur J Neurol. 2002;9:413\u20138.","journal-title":"Eur J Neurol"},{"key":"1084_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cyto.2015.01.009","volume":"73","author":"SJ Ireland","year":"2015","unstructured":"Ireland SJ, Monson NL, Davis LS. Seeking balance: potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10. Cytokine. 2015;73:236\u201344.","journal-title":"Cytokine"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T21:35:16Z","timestamp":1550352916000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1084-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1084-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"12 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the Yokohama City University Hospital (approval number: B121101045). Informed consent was obtained from each participant according to the research ethics of our university hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Research funds were obtained from the Cosmic Corporation. The sponsors had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. No other conflict of interest exists.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"46"}}